Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 4
1992 2
1993 4
1995 4
1996 3
1997 2
1998 3
1999 6
2001 3
2002 4
2003 9
2004 13
2005 12
2006 14
2007 6
2008 7
2009 11
2010 13
2011 13
2012 10
2013 19
2014 14
2015 21
2016 16
2017 31
2018 29
2019 23
2020 39
2021 32
2022 27
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Results by year

Filters applied: . Clear all
Page 1
Skin Metabolomics.
Elpa DP, Chiu HY, Wu SP, Urban PL. Elpa DP, et al. Among authors: wu sp. Trends Endocrinol Metab. 2021 Feb;32(2):66-75. doi: 10.1016/j.tem.2020.11.009. Epub 2020 Dec 19. Trends Endocrinol Metab. 2021. PMID: 33353809 Review.
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial.
Li JX, Wu SP, Guo XL, Tang R, Huang BY, Chen XQ, Chen Y, Hou LH, Liu JX, Zhong J, Pan HX, Shi FJ, Xu XY, Li ZP, Zhang XY, Cui LB, Tan WJ, Chen W, Zhu FC; CanSino COVID-19 Study Group. Li JX, et al. Among authors: wu sp. Lancet Respir Med. 2022 Aug;10(8):739-748. doi: 10.1016/S2213-2600(22)00087-X. Epub 2022 May 20. Lancet Respir Med. 2022. PMID: 35605625 Free PMC article. Clinical Trial.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Zhu FC, et al. Among authors: wu sp. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22. Lancet. 2020. PMID: 32450106 Free PMC article. Clinical Trial.
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma.
Dong ZY, Zhong WZ, Zhang XC, Su J, Xie Z, Liu SY, Tu HY, Chen HJ, Sun YL, Zhou Q, Yang JJ, Yang XN, Lin JX, Yan HH, Zhai HR, Yan LX, Liao RQ, Wu SP, Wu YL. Dong ZY, et al. Among authors: wu sp. Clin Cancer Res. 2017 Jun 15;23(12):3012-3024. doi: 10.1158/1078-0432.CCR-16-2554. Epub 2016 Dec 30. Clin Cancer Res. 2017. PMID: 28039262
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.
Li JX, Hou LH, Gou JB, Yin ZD, Wu SP, Wang FZ, Zhang Z, Peng ZH, Zhu T, Shen HB, Chen W, Zhu FC; Six-Province COVID-19 Vaccine Study Group. Li JX, et al. Among authors: wu sp. Lancet Infect Dis. 2023 Oct;23(10):1143-1152. doi: 10.1016/S1473-3099(23)00350-X. Epub 2023 Jun 20. Lancet Infect Dis. 2023. PMID: 37352880 Clinical Trial.
The role of progesterone receptor isoforms in the myometrium.
Li WN, Dickson MJ, DeMayo FJ, Wu SP. Li WN, et al. Among authors: wu sp. J Steroid Biochem Mol Biol. 2022 Nov;224:106160. doi: 10.1016/j.jsbmb.2022.106160. Epub 2022 Aug 3. J Steroid Biochem Mol Biol. 2022. PMID: 35931328 Free PMC article. Review.
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development.
Ruiz-Garcia A, Baverel P, Bottino D, Dolton M, Feng Y, González-García I, Kim J, Robey S, Singh I, Turner D, Wu SP, Yin D, Zhou D, Zhu H, Bonate P. Ruiz-Garcia A, et al. Among authors: wu sp. J Pharmacokinet Pharmacodyn. 2023 Jun;50(3):147-172. doi: 10.1007/s10928-023-09850-2. Epub 2023 Mar 4. J Pharmacokinet Pharmacodyn. 2023. PMID: 36870005 Free PMC article. Review.
Progesterone Signaling in Endometrial Epithelial Organoids.
Hewitt SC, Wu SP, Wang T, Young SL, Spencer TE, DeMayo FJ. Hewitt SC, et al. Among authors: wu sp. Cells. 2022 May 27;11(11):1760. doi: 10.3390/cells11111760. Cells. 2022. PMID: 35681455 Free PMC article.
384 results